Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision.
Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023 – Biotech Investments
Kinarus Therapeutics Holding AG / Key word(s): Annual Results 28-Feb-2024 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The